illustrates the difficulty we have in placing diagnostic labels on patients with rheumatic complaints. The following case emphasizes this point even further. A 42-year-old gentleman presented in March 1977 with a 10-year history of "rheumatoid arthritis." He admitted to morning stiffness that laste
Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus
โ Scribed by Carmen L. Rosano; Nourollah Parhami; Karim E. Hechemy; Charles Hurwitz
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 488 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0360-3997
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent development of neoplasms. The frequency of neoplasm in SLE patients appeared to be exaggerated, whereas the frequency of subsequent neoplasm in rheumatoid patients was unexpectedly low. A
To quantify soluble Fas/APO-1 (sFas/ APO-1) protein in the serum of patients with systemic lupus erythematosus (SLE) and juvenile rheumatoid arthritis (JRA). Methods. Soluble Fas/APO-1 was quantified using a sandwich enzyme-linked immunosorbent assay. Disease activity in SLE patients was assessed b